Hypotension
Conditions
Keywords
vasopressor, blood pressure, cesarean section, spinal anesthesia
Brief summary
Hypotension is a very common complication of spinal anesthesia for cesarean delivery, and can have unwanted side effects on both mother and fetus if not treated promptly. Phenylephrine has been the drug of choice to treat this spinal-induced hypotension. Although phenylephrine is safe to use for this indication, it has been associated with reflex bradycardia and a reduction in cardiac output. Norepinephrine is a potent vasopressor used to treat hypotension in the critical care setting. Recent studies have looked at norepinephrine's use in the obstetric setting, and have shown that it can be used safely and also has favourable hemodynamic properties when compared to phenylephrine, with less bradycardia and less depression of cardiac output. The investigators recently conducted a study to determine the ED90 of norepinephrine, and now plan to compare bolus doses of phenylephrine to norepinephrine for treating hypotension following spinal anesthesia for cesarean section. The investigators hypothesize that norepinephrine, when given as a bolus to prevent post spinal hypotension, will result in around 70% relative decrease in the rate of bradycardia when compared to phenylephrine in patients undergoing elective cesarean delivery under spinal anesthesia.
Detailed description
Norepinephrine is a potent vasopressor used to treat hypotension in the critical care setting. Recent studies have looked at norepinephrine's use in the obstetric setting, and have shown that it can be used safely and also has favourable hemodynamic properties when compared to phenylephrine, with less bradycardia and less depression of cardiac output. These studies have been limited to using norepinephrine as an infusion and there is limited data with it being used as a bolus to prevent hypotension. A recent study was undertaken at Mount Sinai hospital to determine the ED90 of norepinephrine to treat post spinal hypotension. Secondary outcome data from this trial showed that the incidence of bradycardia associated with this treatment is approximately 7.5%, several times less when compared to the reported 30% with phenylephrine. It would therefore be prudent at this stage to undertake a randomized trial comparing the hemodynamic profile of phenylephrine (our standard practice) and norepinephrine used as intermittent boluses to prevent hypotension and avoid decrease in heart rate during cesarean delivery.
Interventions
DRUGNorepinephrine
Norepinephrine diluted in 5% dextrose solution to a concentration of 6mcg/mL
DRUGPhenylephrine
Phenylephrine diluted in 0.9% normal saline solution to a concentration of 100mcg/mL
Sponsors
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Informed consent * Elective CS under spinal anesthesia * Normal singleton pregnancy beyond 36 weeks gestation * ASA physical status 2-3 * Current (pregnant) weight 50-100 kg, height 150-180 cm * Age over 18 years
Exclusion criteria
* Patient refusal * Inability to communicate in English * Allergy or hypersensitivity to phenylephrine * Preexisting or pregnancy-induced hypertension * Cardiovascular or cerebrovascular disease * Fetal abnormalities * History of diabetes, excluding gestational diabetes * Contra-indications for spinal anesthesia * Allergy or hypersensitivity to sulfite * Use of monoamine oxidase inhibitors, triptyline or imipramine antidepressants * Untreated hyperthyroid patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bradycardia: Heart rate less than 50 bpm | 30 minutes | Heart rate less than 50 bpm, from induction of spinal anesthesia |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of hypotensive episodes | 30 minutes | The number of times the systolic blood pressure measures below 80% of baseline, from induction of spinal anesthesia to delivery of the fetus. |
| Hypertension: Systolic blood pressure at or above 120% of baseline | 30 minutes | Systolic blood pressure at or above 120% of baseline, from induction of spinal anesthesia to delivery of the fetus. |
| Tachycardia: Heart rate greater than 30% of baseline | 30 minutes | Heart rate greater than 30%, from induction of spinal anesthesia to delivery of the fetus. |
| Presence of nausea | 30 minutes | Presence of nausea in patients from induction of spinal anesthesia to delivery of the fetus. |
| Number of episodes of nausea | 30 minutes | The number of episodes of nausea experienced by patients from induction of spinal anesthesia to delivery of the fetus. |
| Presence of vomiting | 30 minutes | Presence of vomiting in patients from induction of spinal anesthesia to delivery of the fetus. |
| Number of episodes of vomiting | 30 minutes | The number of episodes of vomiting experienced by patients from induction of spinal anesthesia to delivery of the fetus. |
| Total dose of study drug given | 30 minutes | Total dose of study drug given from induction of spinal anesthesia to delivery of the fetus. |
| Apgar scores | 1 minute and 5 minutes | The Apgar scores of the infant at 1 and 5 minutes post delivery. |
| Hypotension: Systolic blood pressure less than 80% of baseline | 30 minutes | Systolic blood pressure below 80% of baseline, from induction of spinal anesthesia to delivery of the fetus. |
| Umbilical artery partial pressure of carbon dioxide | 24 hours | Umbilical artery partial pressure of carbon dioxide |
| Umbilical artery partial pressure of oxygen | 24 hours | Umbilical artery partial pressure of oxygen |
| Umbilical artery bicarbonate (mmol/L) | 24 hours | Umbilical artery bicarbonate |
| Umbilical artery base excess (mmol/L) | 24 hours | Umbilical artery base excess |
| Umbilical vein pH | 24 hours | Umbilical vein pH |
| Umbilical vein partial pressure of carbon dioxide | 24 hours | Umbilical vein partial pressure of carbon dioxide |
| Umbilical vein partial pressure of oxygen | 24 hours | Umbilical vein partial pressure of oxygen |
| Umbilical vein bicarbonate (mmol/L) | 24 hours | Umbilical vein bicarbonate |
| Umbilical vein base excess (mmol/L) | 24 hours | Umbilical vein base excess |
| Umbilical artery pH | 24 hours | Umbilical artery pH |
Countries
Canada
Outcome results
None listed